Work

Supplemental Table 2 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Year: 2023
Type: supplementary-materials
Abstract: Tissue next-generation sequencing gene coverage. A: Illumina TruSeq panel (47 genes), and B: Penn Precision Panel (20 genes)
Language: English
Subfield: Cancer Research
Open Access status: gold
OpenAlex ID: W4362403904
Cites:
Cited by:
Related to: 10